Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction. (Q50723601)
Jump to navigation
Jump to search
scientific article published in July 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction. |
scientific article published in July 2000 |
Statements
1 reference
Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction. (English)
1 reference
P Devroey
1 reference
M Ludwig
1 reference
R E Felberbaum
1 reference
C Albano
1 reference
H Riethmüller-Winzen
1 reference
A Schüler
1 reference
W Engel
1 reference
K Diedrich
1 reference
1 July 2000
1 reference
264
1 reference
1
1 reference
29-32
1 reference
Identifiers
1 reference
1 reference